44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pharmacology and Medicinal Chemistry

Sign up for email alert when new content gets added: Sign up

Burçin Nilay Yener1*, Necla Benlier2 and Hülya Çicek1
 
1 Department of Medical Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey, Email: nbenlier@hotmail.com
2 Department of Medical Pharmacology, Faculty of Medicine, Sanko University, Gaziantep, Turkey
 
*Correspondence: Burçin Nilay Yener, Department of Medical Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey, Tel: +918886042417, Email: nbenlier@hotmail.com

Received: 26-Feb-2019 Accepted Date: Mar 07, 2019; Published: 13-Mar-2019

Citation: Yener B, Benlier N, Çicek H. Assessment of cell viability in an astrocytecell line exposed to amyloid beta peptide and Fasudil. J Pharmacol Res2019;3(1):1-4.

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@pulsus.com

Abstract

Background: Amyloid beta (Aβ) is a protein of 40-42 aminoacids that are crucially involved in Alzheimer’s disease as the main component of amyloid plaques. Rho-kinase is believed to be involved in the regulation of stress fiber formation, smooth muscle contraction, cell migration and proliferation. Rho-kinase inhibition results in reduced inflammatory response. Fasudil is a ROCK inhibitor. In the present study, we aimed to evaluate cell viability in an astrocyte cell line treated with amyloid beta peptide and fasudil.

Methods and results: C8-D1A (a murine astrocyte cell line) was used to construct a neurotoxicity model induced by Aβ peptide. Astrocyte cells were divided into 2 groups including control and amyloid beta groups and incubated with 5 μM amyloid beta for 24 hours. A separate group was treated with 2.5 μM dose of Fasudil, a Rho-kinase inhibitor, and photographs of the resulting cell samples were taken with 40X magnification objective of the inverted microscope.

A marked increase in cell loss was observed in the group exposed to 5 μM Aβ after incubation in comparison to control group (p<0.001). Fasudil was found to prevent cell loss considerably in the group treated with Fasudil 2.5 μM and Aβ compared to the group treated with Aβ alone (p<0.001).

Conclusion: In the present study, we found that Aβ caused abundant cell death in the murine C8-D1A astrocyte cell line and Fasudil effectively prevented cell loss induced by amyloid beta.

 
Google Scholar citation report
Citations : 19

Journal of Pharmacology and Medicinal Chemistry received 19 citations as per Google Scholar report

pulsus-health-tech
Top